Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD19-chimeric Antigen Receptor T Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT04029038
What this trial is testing

Modified Immune Cells (CD19-CD22 CAR T Cells) in Treating Patients With Recurrent or Refractory CD19 Positive, CD22 Positive Leukemia or Lymphoma

Who this might be right for
CD19 PositiveCD22 PositiveMinimal Residual Disease+7 more
M.D. Anderson Cancer Center
Very early researchNot Yet RecruitingNCT06920446
What this trial is testing

UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Autoimmune Hemolytic Anemia

Who this might be right for
Relapsed / Refractory Autoimmune Hemolytic Anemia
Zhejiang University 18
Testing effectiveness (Phase 2)Looking for participantsNCT04440436
What this trial is testing

Assessment of Safety and Efficacy of IM19 for Recurrent or Refractory (R/R) Non-Hodgkin's Lymphoma(NHL) Patients

Who this might be right for
NHL
Beijing Immunochina Medical Science & Technology Co., Ltd. 52
Very early researchNot Yet RecruitingNCT07416032
What this trial is testing

A Clinical Study Evaluating the Safety and Preliminary Efficacy of Universal Allogeneic CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C)in Patients With Refractory Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia (ITP)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 27
Early research (Phase 1)UnknownNCT03344367
What this trial is testing

Study Evaluating the Safety and Efficacy of JWCAR029 in Adult Subjects With Relapsed and Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
Non Hodgkin Lymphoma
Peking University 20
Early research (Phase 1)Active Not RecruitingNCT02735083
What this trial is testing

Evaluate the Long-term Safety of Patients With Advanced Lymphoid Leukemia Who Have Been Previously Administered With UCART19

Who this might be right for
Advanced Lymphoid Leukemia
Institut de Recherches Internationales Servier 28
Testing effectiveness (Phase 2)Looking for participantsNCT07288879
What this trial is testing

DALY II Japan/MB-CART2019.1 for DLBCL

Who this might be right for
DLBCL - Diffuse Large B Cell LymphomaCAR T Cell Therapy
Miltenyi Biomedicine GmbH 31
Very early researchTemporarily pausedNCT06549296
What this trial is testing

Clinical Study on Targeted CD19CAR-T Therapy for Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusSystemic SclerosisANCA Associated Vasculitis+3 more
Nanjing Bioheng Biotech Co., Ltd. 12
Not applicableStudy completedNCT05784415
What this trial is testing

Observational Study of People Living With HIV Treated With CD19-directed CAR T Cell

Who this might be right for
LeukemiaLeukemia, LymphoblasticLymphoma, Large B-Cell, Diffuse+7 more
AIDS Malignancy Consortium 30
Testing effectiveness (Phase 2)Looking for participantsNCT07584889
What this trial is testing

Efficacy and Safety of CD19-CAR.p40-T in Patients With Relapsed/Refractory CD19-Positive Hematologic Malignancies

Who this might be right for
B Cell LymphomaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia
Shenzhen University General Hospital 10
Testing effectiveness (Phase 2)Study completedNCT03792633
What this trial is testing

Study of huCART19 for Very High-Risk (VHR) Subsets of Pediatric B-ALL

Who this might be right for
Acute Lymphoblastic Leukemia
University of Pennsylvania 106
Very early researchUnknownNCT04532268
What this trial is testing

Humanized CD19 CAR-T Cells Therapy for Patients With Relapsed and/or Refractory B-cell ALL and B-cell NHL

Who this might be right for
Acute Lymphoblastic LeukemiaNon-hodgkin Lymphoma,B Cell
Zhejiang University 72
Not applicableLooking for participantsNCT07558850
What this trial is testing

Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases

Who this might be right for
Rheumatoid ArthritisDermatomyositisSystemic Lupus Erythematosus+1 more
The First Affiliated Hospital with Nanjing Medical University 72
Very early researchLooking for participantsNCT06446128
What this trial is testing

A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed or Refractory B Cell Non-Hodgkin Lymphoma(NHL)

Who this might be right for
Non-Hodgkin Lymphoma, B-cell
Shanghai Cell Therapy Group Co.,Ltd 20
Testing effectiveness (Phase 2)UnknownNCT04163302
What this trial is testing

Safety and Efficiency Study of CD19-PD1-CART Cell in Relapsed/Refractory B Cell Lymphoma

Who this might be right for
Lymphoma, B-Cell
Chinese PLA General Hospital 30
Testing effectiveness (Phase 2)UnknownNCT05744037
What this trial is testing

Clinical Study of the Safety and Efficacy of the R/R B-NHL Regimen With BTK Inhibitor+Anti-CD19 CAR-T Cells

Who this might be right for
B-cell Non Hodgkin Lymphoma
The Affiliated Hospital of Xuzhou Medical University 30
Very early researchUnknownNCT05651191
What this trial is testing

To Evaluate the Safety and Efficacy of Human CD19 Targeted DASH CAR-T Cells Injection for Subjects With R/R B-ALL

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Hrain Biotechnology Co., Ltd. 9
Very early researchNot Yet RecruitingNCT06986018
What this trial is testing

Clinical Study on the Targeted CD19 Universal CAR-T Cell Injection (RD06-04) for the Treatment of IIM and AAV

Who this might be right for
Idiopathic Inflammatory MyopathiesANCA-Associated Vasculitis
Peking University People's Hospital 12
Testing effectiveness (Phase 2)UnknownNCT02652910
What this trial is testing

Memory-enriched CAR-T Cells Immunotherapy for B Cell Lymphoma

Who this might be right for
Recurrent Adult Diffuse Large Cell LymphomaRecurrent Follicular LymphomaRecurrent Mantle Cell Lymphoma+6 more
Xinqiao Hospital of Chongqing 20
Early research (Phase 1)UnknownNCT04303520
What this trial is testing

Anti-CD19/CD22 Bispecific CAR-T Cell Therapy for CD19-positive ALL

Who this might be right for
CD19-positive ALL
The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine 20
Next Page